Original Source(s)
Combination Therapy Shows Potential in Psoriasis, Obesity
-
by Kathryn Wighton
May 20, 2026
Related Content
Ivarmacitinib Eased Refractory PCA: Case Report
Off-label ivarmacitinib rapidly relieved pruritus and improved skin lesions in a patient with refractory primary cutaneous amyloidosis, according to a case report.
May 20, 2026
-
4 min
Why FDA Said No to a Melanoma Drug
Questions over trial design and political pressure shadowed the rejection of Replimune’s RP1 treatment.
by Arthur Allen
May 15, 2026
-
9 min
Guselkumab Shows Psoriasis Benefit in Darker Skin Tones
Randomized trial suggests sustained clearance across darker skin tones.
May 14, 2026
-
3 min
